These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 941920)

  • 41. Justification and implementation of a cancer center pharmacy satellite.
    Sauer KA; Nowak MM; Coons SJ; Parr MD; McIntyre WJ
    Am J Hosp Pharm; 1989 Jul; 46(7):1389-92. PubMed ID: 2757046
    [TBL] [Abstract][Full Text] [Related]  

  • 42. P & T Committee problem-solving in a Canadian specialty hospital.
    Feld R
    Hosp Formul; 1986 Jul; 21(7):778-9, 783-4. PubMed ID: 10277344
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A new approach to delivering drug information to the physician through a pharmacy consultation program. IV. Evaluation results.
    Bell JE; Bouchard VE; South JC; Duffy GM
    Am J Hosp Pharm; 1973 Apr; 30(4):300-10. PubMed ID: 4697653
    [No Abstract]   [Full Text] [Related]  

  • 44. The P & T Committee Part 2: involvement by pharmacy, medical, and nursing personnel.
    Bender FH
    Hosp Formul; 1983 Jul; 18(7):692-6. PubMed ID: 10260988
    [TBL] [Abstract][Full Text] [Related]  

  • 45. P & T Committee role in advocating rational therapeutics.
    Borreson R
    Hosp Formul; 1986 May; 21(5):590-8. PubMed ID: 10311625
    [TBL] [Abstract][Full Text] [Related]  

  • 46. How drugs attain formulary listing.
    Rolands TF; Williams RB
    Hospitals; 1975 Jan; 49(2):87-9. PubMed ID: 1088948
    [No Abstract]   [Full Text] [Related]  

  • 47. Hospital formularies: organizational aspects and supplementary components.
    Rucker TD; Visconti JA
    Am J Hosp Pharm; 1976 Sep; 33(9):912-7. PubMed ID: 984056
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Strengthening the formulary system by implementing a drug usage guidelines program.
    Huber SL; Patry RA; Hudson HD; Godwin HN
    Hosp Formul; 1984 Aug; 19(8):664-8. PubMed ID: 10267390
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A multidisciplinary process to determine, communicate, and manage an antibiotic formulary.
    Cook AA; Sanchez ML
    Hosp Pharm; 1992 Oct; 27(10):867-9, 872-4, 882. PubMed ID: 10121423
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Controlling cephalosporin and aminoglycoside costs through pharmacy and therapeutics committee restrictions.
    Hayman JN; Sbravati EC
    Am J Hosp Pharm; 1985 Jun; 42(6):1343-7. PubMed ID: 4014250
    [TBL] [Abstract][Full Text] [Related]  

  • 51. P & T Committee perspectives: maintaining a successful formulary system in a private community hospital.
    Benner EJ; Mykita L; Brown K
    Hosp Formul; 1990 Apr; 25(4):423-6, 428, 430. PubMed ID: 10104233
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacy and Therapeutics committee. Cost-containment considerations.
    Hochla PK; Tuason VB
    Arch Intern Med; 1992 Sep; 152(9):1773-5. PubMed ID: 1520043
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diffusion of innovation II: Formulary acceptance rates of new drugs in teaching and non-teaching British Columbia hospitals--a drug development perspective.
    D'Sa MM; Hill DS; Stratton TP
    Can J Hosp Pharm; 1995 Feb; 48(1):7-15. PubMed ID: 10141063
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Developing a unit-of-use drug distribution system for the hospital emergency room.
    Schiavone JD
    Hosp Pharm; 1981 Apr; 16(4):208-9, 214-5, 219 passim. PubMed ID: 10251101
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Perceptions, experiences, and expectations of physicians in hospital settings in Jordan regarding the role of the pharmacist.
    Tahaineh LM; Wazaify M; Albsoul-Younes A; Khader Y; Zaidan M
    Res Social Adm Pharm; 2009 Mar; 5(1):63-70. PubMed ID: 19285290
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An inside look at the UCLA P&T committee: how does it influence prescribing practices?
    Conolly ME
    Hosp Formul; 1986 Feb; 21(2):214-7. PubMed ID: 10275576
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diffusion of innovation I: Formulary acceptance rates of new drugs in teaching and non-teaching British Columbia hospitals--a hospital pharmacy perspective.
    D'Sa MM; Hill DS; Stratton TP
    Can J Hosp Pharm; 1994 Dec; 47(6):254-60. PubMed ID: 10139270
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug usage review and inventory analysis in promoting rational parenteral cephalosporin therapy.
    Simon WA; Thompson L; Campbell S; Lantos RL
    Am J Hosp Pharm; 1975 Nov; 32(11):1116-21. PubMed ID: 1190230
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessing whether a clinical pharmacy program is meeting its goals.
    Fink A; Kosecoff J; Oppenheimer PR; Smith WE; Brodie DC
    Am J Hosp Pharm; 1982 May; 39(5):806-10. PubMed ID: 7081251
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drug information centers: ASHP's role and effect of clinical pharmacy.
    Walton CA; Knodel LC
    Am J Hosp Pharm; 1983 Jul; 40(7):1217-8. PubMed ID: 6881164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.